Aratana Therapeutics Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
47.67 M |
Public Float |
39.61 M |
Aratana Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.27 |
Market Cap |
$252.86 M |
Shares Outstanding |
49 M |
Public Float |
46.65 M |
Address |
11400 Tomahawk Creek Parkway Leawood Kansas 66211 United States |
Employees | - |
Website | http://www.aratana.com |
Updated | 07/08/2019 |
Aratana Therapeutics, Inc. operates as a development stage biopharmaceutical company, which focuses on the licensing, development and commercialization of innovative prescription medications for pets or pet therapeutics. It delivers prescription medicines that address significant medical needs for cats and dogs. The firm licenses proprietary, patent-protected compounds from human pharmaceutical and biotechnology companies. |